Assessment and management of serotonin syndrome in a simulated patient study of Australian community pharmacies | Zendy

Brett MacFarlane | Zendy; Jenny Bergin | Zendy; Gregory M. Peterson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessment and management of serotonin syndrome in a simulated patient study of Australian community pharmacies

Author(s) -

Brett MacFarlane,

Jenny Bergin,

Gregory M. Peterson

Publication year - 2016

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2016.02.703

Subject(s) - serotonin syndrome , medicine , tramadol , pharmacy , pharmacist , family medicine , serotonin , psychiatry , serotonergic , analgesic , receptor

While not identifying the cause of the simulated patient's symptoms in the majority of cases, community pharmacies recommended appropriate action to minimise the health impact of serotonin syndrome by advising to cease tramadol and/or referring to a doctor and not recommending non-prescription medicines to treat symptoms. Raising pharmacists' awareness of the signs and symptoms of serotonin syndrome, and the importance of taking a comprehensive medication history when assessing a set of symptoms, may help community pharmacies further reduce serotonin syndrome toxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research